AKTX Akari Therapeutics enters strategic research collaboration with Whitehawk Therapeutics Akari Therapeutics - Co and Whitehawk to conduct
AKTX Akari Therapeutics enters strategic research collaboration with Whitehawk Therapeutics Akari Therapeutics - Co and Whitehawk to conduct preclinical studies of ph1 payload with top1i Adc platform - Collaboration to commence immediately with interim data updates anticipated
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.